Ventana Medical Systems' (Ventana) CONFIRM anti-Cytokeratin 7 (SP52) Rabbit Monoclonal Primary Antibody (CONFIRM anti-Cytokeratin 7 (SP52) antibody) is directed against a type II cytokeratin protein expressed by most ductal, glandular and transitional epithelia. Cytokeratin 7 exhibits a cytoplasmic localization. This antibody may be used to aid in the identification of normal and neoplastic cells of ovary, lung and breast epithelial origin which express Cytokeratin 7, and those of colonic and prostate epithelial lineage which lack Cytokeratin 7 production. The antibody is intended for qualitative staining in sections of formalin-fixed, paraffin-embedded tissue.
This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information and proper controls.
This antibody is intended for in vitro diagnostic (IVD) use.